SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Playing the QQQQ with Terry and friends.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jill who wrote (443)5/26/2005 11:34:08 AM
From: Kevin  Read Replies (1) of 4814
 
I thought this was an interesting quote that I read on the Bloomberg this morning, regarding Elan's situation:

``Without Tysabri, Elan is dead,'' said Andy Smith, who
manages $50 million in assets at Bioscience Investment Trust at Schroder in London, and who doesn't hold Elan shares. "This is not a case of a chief executive being optimistic; he's fighting for survival with a drug that's been shown to kill two patients.''

Personally I've never been comfortable owning shares in a company with a single product (or single client).

-K
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext